VIADERM KC CRM CREAM

Country: Canada

Language: English

Source: Health Canada

Active ingredient:

TRIAMCINOLONE ACETONIDE; NEOMYCIN (NEOMYCIN SULFATE); GRAMICIDIN; NYSTATIN

Available from:

TARO PHARMACEUTICALS INC

ATC code:

D07CB01

INN (International Name):

TRIAMCINOLONE AND ANTIBIOTICS

Dosage:

1MG; 2.5MG; 0.25MG; 100000UNIT

Pharmaceutical form:

CREAM

Composition:

TRIAMCINOLONE ACETONIDE 1MG; NEOMYCIN (NEOMYCIN SULFATE) 2.5MG; GRAMICIDIN 0.25MG; NYSTATIN 100000UNIT

Administration route:

TOPICAL

Units in package:

15/30/60/454GM

Prescription type:

Prescription

Therapeutic area:

ANTIBIOTICS

Product summary:

Active ingredient group (AIG) number: 0405625002; AHFS:

Authorization status:

MARKETED

Authorization date:

1983-12-31

Summary of Product characteristics

1
PRESCRIBING INFORMATION
AND
PATIENT MEDICATION INFORMATION
PR
VIADERM K.C.
® CREAM
PR
VIADERM K.C.
® OINTMENT
(Triamcinolone Acetonide 1 mg/g, Nystatin 100,000 units/g,
Neomycin base (as sulphate) 2.5 mg/g, and Gramicidin 0.25 mg/g)
Topical corticosteroid, anti-inflammatory, antibacterial and
antifungal agents
Taro Pharmaceuticals Inc
130 East Drive
Brampton, ON
L6T 1C1
Date of Revision:
July 5, 2018
Submission Control No. 214456
2
TABLE OF CONTENTS
PART I: HEALTH PROFESSIONAL INFORMATION
.........................................................3
SUMMARY PRODUCT INFORMATION
........................................................................3
INDICATIONS AND CLINICAL USE
.............................................................................3
CONTRAINDICATIONS
...................................................................................................3
WARNINGS AND PRECAUTIONS
.................................................................................4
ADVERSE REACTIONS
...................................................................................................6
DOSAGE AND ADMINISTRATION
................................................................................6
OVERDOSAGE
..................................................................................................................6
ACTION AND CLINICAL PHARMACOLOGY
..............................................................7
STORAGE AND STABILITY
...........................................................................................7
DOSAGE FORMS, COMPOSITION AND PACKAGING
...............................................7
PART II: SCIENTIFIC INFORMATION
.................................................................................8
PHARMACEUTICAL INFORMATION
............................................................................8
PART III: PATIENT MEDICATION INFORMATION
........................................................10
3
PR
VIADERM K.C.
® CREAM
PR
VIADERM K.C.
® OINTMENT
(Triamcinolone Acetonide